Substrate
health

Trump Administration Seeks Next FDA Commissioner to Rebuild Trust and Advance Reforms

The administration is moving quickly to find a successor after FDA Commissioner Marty Makary resigned on Tuesday. Officials want the next leader to rebuild trust with agency staff, emphasize food policy and continue drug-approval reforms. The search is expected to take several weeks amid a busy Senate confirmation calendar.

Stat
1 source·May 13, 6:21 PM(7 hrs ago)·1m read
Trump Administration Seeks Next FDA Commissioner to Rebuild Trust and Advance Reformsthehindu.com
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

The Trump administration is moving quickly to identify the next commissioner of the Food and Drug Administration after the resignation of Marty Makary on Tuesday. Administration officials are looking for someone who can rebuild trust with agency staff, focus on the agency’s food policy and continue to drive drug-approval reforms.

An official with knowledge of the process, granted anonymity to speak candidly, said leaders hope to conduct the search over the next several weeks. Despite chatter among lobbyists about potential candidates, there is currently no short list, the official said.

The process is expected to take time even with the sense of urgency.

The Senate is in session for a limited number of days in the coming weeks. Officials also need to confirm the Centers for Disease Control and Prevention nominee and the surgeon general nominee before turning full attention to the FDA role. It is possible that the former head of the FDA’s food center will remain acting commissioner through the November midterms.

The development was reported by STAT on May 13, 2026.

Key Facts

Marty Makary resigned
as FDA commissioner on Tuesday
Search timeline
expected over next several weeks
No short list
of candidates currently exists
Priorities for successor
rebuild staff trust, food policy, drug reforms
Acting commissioner
could serve until November midterms

Potential Impact

  1. 01

    The FDA will operate with an acting commissioner for an extended period.

  2. 02

    Senate confirmation schedule may delay installation of permanent commissioner.

  3. 03

    Food policy and drug-approval initiatives are expected to remain agency priorities.

  4. 04

    Agency staff trust-building is listed as a key qualification for the new leader.

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count178 words
PublishedMay 13, 2026, 6:21 PM
Bias signals removed3 across 2 outlets
Signal Breakdown
Editorializing 1Speculative 1Framing 1

Related Stories

Trump Sides With Tobacco Industry in Vape Disputerediff.com
health11 hrs agoDeveloping

Trump Sides With Tobacco Industry in Vape Dispute

President Trump intervened in a regulatory dispute over vaping products, supporting tobacco companies against a position held by his own administration's officials. The Food and Drug Administration commissioner resigned in protest following the decision. The New York Times report…

The New York Times
1 source
NYU Langone Receives Federal Grand Jury Subpoena on Gender-Affirming Care for MinorsStat
health11 hrs agoFraming65Framing risk65/100Rewrite inherits heavy consensus framing from sources by centering the subpoena as an aggressive Trump-era escalation while burying the substantive event of potential fraud in pediatric gender care.Click to jump to full framing analysis

NYU Langone Receives Federal Grand Jury Subpoena on Gender-Affirming Care for Minors

NYU Langone Health disclosed last week that it received a grand jury subpoena from the U.S. Attorney’s Office in the Northern District of Texas seeking records on minors who received gender-affirming care from 2020 to 2026. The request marks a shift from prior administrative subp…

Stat
Hot Air
2 sources
Kennedy Spokesman Resigns Over Flavored E-Cigarette Policynbcnews.com
health9 hrs agoDeveloping

Kennedy Spokesman Resigns Over Flavored E-Cigarette Policy

A spokesman for the Kennedy organization resigned in a letter to President Trump. The official opposed a decision to permit the sale of flavored e-cigarettes, stating it would increase their appeal to children. The New York Times reported the resignation on May 13, 2026.

The New York Times
joemygod.com
2 sources